Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gritstone Bio
Gritstone Bio
Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024
BioSpace
Tue, 04/30/24 - 08:31 am
Gritstone Bio
samRNA
vaccines
COVID
Gritstone shares fall on shaky study results for colorectal cancer vaccine
BioPharma Dive
Tue, 04/2/24 - 11:36 am
Gritstone Bio
colorectal cancer
clinical trials
cancer vaccines
Gritstone lays off 40% of team after delayed launch of COVID vax trial
Fierce Biotech
Thu, 02/29/24 - 06:59 pm
Gritstone Bio
layoffs
vaccines
COVID-19
‘Project NextGen’ picks new mRNA, intranasal COVID vaccines for funding
BioPharma Dive
Fri, 10/13/23 - 12:01 pm
Project NextGen
MRNA
COVID-19
vaccines
funding
Gritstone Bio
Codagenix
CastleVax
Gritstone bio wins $433 million US contract for COVID vaccine study
Reuters
Wed, 09/27/23 - 11:14 pm
Gritstone Bio
vaccines
COVID-19
MRNA
federal contracts
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
Clinical Trials Arena
Thu, 06/8/23 - 09:32 pm
Gritstone Bio
clinical trials
MRNA
samRNA
vaccines
COVID-19
Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)
BioSpace
Tue, 12/13/22 - 10:27 am
Gritstone Bio
MRNA
samRNA
patents
JPM22, Day 4: Vertex aims to be cystic fibrosis leader into the 2030s; Gritstone hopes for new colorectal cancer biomarker
Fierce Biotech
Thu, 01/13/22 - 11:12 am
JPMHC 2022
Vertex Pharmaceuticals
Gritstone Bio
Gritstone bio trumpets first data for ‘multivariant’ COVID jab
Pharmaforum
Wed, 01/5/22 - 10:43 am
Gritstone Bio
vaccines
COVID-19
Does This Biotech Have the Secret to Conquering Covid Variants?
Motley Fool
Wed, 09/29/21 - 10:59 am
Gritstone Bio
vaccines
COVID-19
COVID-19 variants
Self-amplifying mRNA COVID-19 vaccine 'immunogenicity enhancer’ enters Phase 1 trial
Biopharma Reporter
Mon, 09/20/21 - 11:50 am
Gritstone Bio
clinical trials
vaccines
COVID-19
MRNA
immunogenicity enhancer
Here's the Biotech Pfizer Should Consider Acquiring Next
Motley Fool
Fri, 09/3/21 - 11:00 am
Pfizer
MRNA
vaccines
BioNTech
Trillium Therapeutics
Gritstone Bio
Gritstone secures CEPI funding to test Covid vaccine; first focus is South Africa
MedCity News
Tue, 08/17/21 - 10:53 pm
Gritstone Bio
vaccines
COVID-19
MRNA
CEPI